Epilepsy trials in Austria
6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Where
- Innsbruck, Linz, Salzburg, Vienna
- Age
- 12 years and over
- People
- 160 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05667142 · EU 2022-502286-16-00 - Phase 3Taking peopleA Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Where
- Innsbruck, Salzburg, Vienna
- Age
- 18 years and over
- People
- 360 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00 - Phase 3Enrolling by invitationAn Open-label Study of XEN1101 in Epilepsy
- Where
- Innsbruck, Linz, Salzburg, Vienna
- Age
- 12 years and over
- People
- 880 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00 - No phaseEnrolling by invitation5-SENSE Score Validation Study
- Where
- Salzburg
- Age
- 15 years and over
- People
- 400 worldwide
- Run by
- Duke University
See details and how to joinNCT06138808 - Phase 2Enrolling by invitationLong-term Safety and Tolerability of BHV-7000
- Where
- Linz, Salzburg, St. Poelten, Vienna
- Age
- 18 years to 75 years
- People
- 660 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00 - Phase 2Taking peopleEpiflux
- Where
- Vienna
- Age
- 18 years and over
- People
- 60
- Run by
- Medical University Of Vienna
See details and how to join2024-515540-23-00 · EU 2024-515540-23-00